Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Neth J Med ; 73(10): 455-63, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26687261

ABSTRACT

BACKGROUND: Publication of the Normoglycemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation (NICE-SUGAR) trial in 2009 and several observational studies caused a change in the recommendations for blood glucose control in intensive care patients. We evaluated local trends in blood glucose control in intensive care units in the Netherlands before and after the publication of the NICE-SUGAR trial and the revised Surviving Sepsis Campaign (SSC) guidelines in 2012. METHODS: Survey focusing on the timing of changes in thresholds in local guidelines for blood glucose control and interrupted time-series analysis of patients admitted to seven intensive care units in the Netherlands from September 2008 through July 2014. Statistical process control was used to visualise and analyse trends in metrics for blood glucose control in association with the moment changes became effective. RESULTS: Overall, the mean blood glucose level increased and the median percentage of blood glucose levels within the normoglycaemic range and in the hypoglycaemic range decreased, while the relative proportion of hyperglycaemic measurements increased. Changes in metrics were notable after publication of the NICE-SUGAR trial and the SSC guidelines but more frequent after changes in local guidelines; some changes seemed to appear independent of changes in local guidelines. CONCLUSION: Local guidelines for blood glucose practice have changed in intensive care units in the Netherlands since the publication of the NICE-SUGAR trial and the revised SSC guidelines. Trends in the metrics for blood glucose control suggest new, higher target ranges for blood glucose control.


Subject(s)
Critical Care/trends , Critical Illness , Hyperglycemia/drug therapy , Hypoglycemic Agents/therapeutic use , Practice Patterns, Physicians'/trends , Registries , Aged , Algorithms , Blood Glucose , Clinical Protocols , Female , Guideline Adherence , Humans , Hypoglycemia/chemically induced , Male , Middle Aged , Netherlands , Patient Care Planning , Practice Guidelines as Topic
2.
Ned Tijdschr Geneeskd ; 144(40): 1923-6, 2000 Sep 30.
Article in Dutch | MEDLINE | ID: mdl-11045142

ABSTRACT

A 52-year-old woman with a medical history of diabetes mellitus type 2, chronic alcoholism and liver function disorders was hospitalized because of complaints of haematemesis, abdominal complaints and dyspnoea. This was due to a severe lactic acidosis caused by acute alcohol intoxication and the use of metformin. With bicarbonate infusion and haemofiltration, the lactic acidosis disappeared, but she developed a distributive shock with multiple organ failure and died 23 days after admission. Lactic acidosis is a rare but serious adverse effect of metformin. Almost all patients described had contraindications to the drug, like renal failure, liver disease, alcohol abuse, and intercurrent conditions causing hypoxia or ischaemia. It is important to be aware of the circumstances in which metformin should not be prescribed.


Subject(s)
Acidosis, Lactic/chemically induced , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/adverse effects , Liver Cirrhosis, Alcoholic/complications , Metformin/adverse effects , Acidosis, Lactic/complications , Alcoholic Intoxication/complications , Contraindications , Diabetes Mellitus, Type 2/complications , Fatal Outcome , Female , Humans , Middle Aged , Multiple Organ Failure/etiology
3.
Ned Tijdschr Geneeskd ; 144(25): 1228-30, 2000 Jun 17.
Article in Dutch | MEDLINE | ID: mdl-10897303

ABSTRACT

A woman aged 66 was prescribed acetazolamide (Diamox) in the outpatient clinic because of glaucoma. She went into irreversible anaphylactic shock with massive pulmonary oedema, probably due to a cross reaction in sulphonamide allergy. Before prescribing acetazolamide, the physician should inquire about sulphonamide allergy because of the related chemical structure of the substances. Such an allergy should be regarded as a contraindication.


Subject(s)
Acetazolamide/adverse effects , Anaphylaxis/chemically induced , Diuretics/adverse effects , Glaucoma/drug therapy , Acetazolamide/pharmacology , Aged , Contraindications , Diuretics/pharmacology , Drug Hypersensitivity/complications , Drug Interactions , Fatal Outcome , Female , Humans , Pulmonary Edema/chemically induced , Sulfonamides/adverse effects
4.
Eur J Clin Pharmacol ; 47(4): 325-30, 1994.
Article in English | MEDLINE | ID: mdl-7875183

ABSTRACT

In order to compare ibopamine (IBO), a dopamine congener, with isosorbide mononitrate (ISMN) and to study their interaction in effects on the capacitance vasculature in congestive heart failure (CHF), a prospective, randomized, placebo-controlled, double-blind clinical trial was performed in 32 patients with New York Heart Association class II-IV CHF, randomly assigned to receive single oral doses of placebo, 200 mg IBO, 20 mg ISMN, or both IBO and ISMN. After labelling of red cells with 99mTc, changes in regional radioactivity, indicative of changes in blood volume, were recorded using a gamma-camera before and at 30, 60 and 120 min after drug administration. At 30 and 60 min, arterial systolic and pulse pressures were higher with IBO than with ISMN and placebo (for pulse pressure by mean 13.7 mmHg, 95% confidence interval 4.5-23.0 mmHg, at 30 min), probably reflecting an IBO-induced rise in stroke volume at unchanged heart rate and mean arterial pressure. IBO did not change regional radioactivity except for a transient increase of 4.4% (0.5-7.6%) in the thorax at 30 min. This was attenuated by concomitant ISMN treatment since, starting at 30 min, the drug increased radioactivity in the legs, compared with patients not receiving the drug, by 8.0% (95% confidence interval 0.2-15.8%), leading to a fall in thoracic and left ventricular radioactivity at 30 min of 3.4% (0.3-7.0%) and 6.4% (0.8-11.9%), respectively, and a fall of 5.5% (0.5-10.5%) in hepatic radioactivity at 60 min.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Blood Volume/drug effects , Deoxyepinephrine/analogs & derivatives , Heart Failure/drug therapy , Isosorbide/pharmacology , Aged , Deoxyepinephrine/pharmacology , Double-Blind Method , Drug Interactions , Female , Heart Failure/diagnostic imaging , Hemodynamics , Humans , Male , Middle Aged , Radionuclide Imaging , Technetium Tc 99m Pentetate
5.
Clin Nephrol ; 34(2): 70-1, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2225556

ABSTRACT

A 55-year-old man developed renovascular hypertension that was characterized by high plasma renin activity. This was accompanied by nephrotic range proteinuria. Treatment with nifedipine and furosemide lowered the blood pressure to normal values, but proteinuria persisted. However, treatment with an ACE-inhibitor brought resolution of the proteinuria, suggesting a role for angiotensin II in urinary protein loss.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Hypertension, Renovascular/complications , Proteinuria/drug therapy , Renin/blood , Humans , Hypertension, Renovascular/metabolism , Male , Middle Aged
6.
Neth J Med ; 35(1-2): 38-43, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2779693

ABSTRACT

Exertion-induced heat stroke is a relatively rare disorder in the moderate maritime climate of The Netherlands. Serious complications of excessive physical activity rarely occur. We describe a marathon runner with multi-organ failure after exertion-induced heat stroke. The patient developed shock, diarrhoea, coma, rhabdomyolysis, acute renal failure, liver cell damage and disseminated intravascular coagulation but recovered completely.


Subject(s)
Heat Exhaustion/physiopathology , Running , Adult , Heat Exhaustion/blood , Heat Exhaustion/etiology , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...